The Division of Pediatrics and Maternal Health (DPMH) oversees quality initiatives which promote and necessitate the study of drug and biological products in the pediatrics, pregnant women, and breastfeeding populations and improve pregnancy and lactation-related information in product labeling.
What is DPMH’s Role?
To collaborate to develop clinically relevant, evidence-based labeling and other communications that facilitate informed use of drugs and biologics in children, pregnant females, lactating females, and females and males of reproductive potential.
Division Director: Lynne Yao
Deputy Director: John Alexander
Director of Pharm/Tox for Rare Diseases, Pediatrics, Urologic and Reproductive Medicine: Mukesh Summan (Acting)
Director of Project Management Staff: Rosemary Addy
Food and Drug Administration
Center for Drug Evaluation and Research
Office of New Drugs
10903 New Hampshire Avenue
Silver Spring, MD 20993
Main Line: 301-796-2200